Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression

Psychiatry Research

Volumn 141, Issue 3, 2006, Pages 279-286

  Parker, Gordon B ^a,b   Heruc, Gabriella A ^a,b   Hilton, Therese M ^a,b   Olley, Amanda ^a,b   Brotchie, Heather ^b   Hadzi Pavlovic, Dusan ^a,b   Friend, Cheryl ^b   Walsh, Warren F ^b   Stocker, Roland ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cardiovascular disease; Coronary artery disease; Fatty acids; Major depressive disorder; Mood disorder; Omega 3 polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MALE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RATING SCALE;

ACUTE DISEASE; AGED; CORONARY DISEASE; DEPRESSIVE DISORDER, MAJOR; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; MALE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 33645301006     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2005.08.005     Document Type: Article

References (39)

1. J. Abramson, A. Berger, H. Krumholz, and V. Vaccarino Depression and risk of heart failure among older persons with isolated systolic hypertension Archives of Internal Medicine 161 2001 1725 1730
2. P.B. Adams, S. Lawson, A. Sanigorski, and A.J. Sinclair Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression Lipids 31 Suppl 1 1996 157 161
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Press Washington, DC
4. A.A. Ariyo, M. Haan, C. Tangen, J.C. Rutledge, M. Cushman, A. Dobs, and C.D. Furberg Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans Circulation 102 2000 1773 1779
5. A. Ascherio, E.B. Rimm, M.J. Stampfer, E.L. Giovannucci, and W.C. Willett Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men New England Journal of Medicine 332 1995 977 982
6. J.C. Barefoot, and M. Schroll Symptoms of depression, acute myocardial infarction, and total mortality in a community sample Circulation 93 1996 1976 1980
7. B.H. Brummett, M.A. Babyak, I.C. Siegler, D.B. Mark, R.B. Williams, and J.C. Barefoot Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease American Journal of Cardiology 92 2003 529 532
8. M.L. Burr, A.M. Fehily, J.F. Gilbert, S. Rogers, R.M. Holliday, P.M. Sweetnam, P.C. Elwood, and N.M. Deadman Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) Lancet 2 1989 757 761
9. D.E. Bush, R.C. Ziegelstein, M. Tayback, D. Richter, S. Stevens, H. Zahalsky, and J.A. Fauerbach Even minimal symptoms of depression increase mortality risk after acute myocardial infarction American Journal of Cardiology 88 2001 337 341
10. R.M. Carney, K.E. Freedland, S.A. Eisen, M.W. Rich, and A.S. Jaffe Major depression and medication adherence in elderly patients with coronary artery disease Health Psychology 14 1995 88 90
11. J.H. Christensen, P. Gustenhoff, E. Korup, J. Aaroe, E. Toft, J. Moller, K. Rasmussen, J. Dyerberg, and E.B. Schmidt Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double-blind randomized controlled trial British Medical Journal 312 1996 677 678
12. I. Connerney, P.A. Shapiro, J.S. McLaughlin, E. Bagiella, and R.P. Sloan Relation between depression after coronary bypass surgery and 12 month outcome: a prospective study Lancet 358 2001 1766 1771
13. U.N. Das Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins, Leukotrienes and Essential Fatty Acids 63 2000 351 362
14. M. de Lorgeril, P. Salen, J.-L. Martin, I. Monjaud, J. Delaye, and N. Mamelle Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study Circulation 99 1999 779 785
15. W.W. Eaton, H. Armenian, J. Gallo, L. Pratt, and D.E. Ford Depression and risk for onset of type II diabetes Diabetes Care 19 1996 1097 1102
16. N. Frasure-Smith, F. Lesperance, and P. Julien Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes Biological Psychiatry 55 2004 891 896
17. GISSI-Prevenzione Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
18. J.R. Hibbeln, J.C. Umhau, D.T. George, and N. Salem Jr. Do plasma polyunsaturates predict hostility and depression? World Review of Nutrition and Dietetics 82 1997 175 186
19. J.R. Hibbeln Fish consumption and major depression [Letter] Lancet 351 1998 1213
20. Hilton, T., Parker, G., McDonald, S., Heruc, G., Olley, A., Brotchie, H., in press. A validation study of two brief measures of depression in the cardiac population: the DMI-10 and DMI-18. Psychosomatics.
21. A. Leaf, and P.C. Weber A new era for the science of nutrition American Journal of Clinical Nutrition 45 1987 1048 1053
22. A. Leaf, and P.C. Weber Cardiovascular effects of n-3 fatty acids New England Journal of Medicine 322 1988 697 698
23. F. Lesperance, N. Frasure-Smith, and M. Talajic Major depression before and after myocardial infarction: its nature and consequences Psychosomatic Medicine 58 1996 99 110
24. 2 in depression Prostaglandins Leukotrienes and Medicine 10 1983 361 367
25. G. Mamalakis, M. Tornaritis, and A. Kafatos Depression and adipose essential polyunsaturated fatty acids Prostaglandins, Leukotrienes and Essential Fatty Acids 67 2002 311 318
26. G. Mamalakis, M. Kiriakakis, G. Tsibinos, and A. Kafatos Depression and adipose polyunsaturated fatty acids in the survivors of the seven countries study population of Crete Prostaglandins, Leukotrienes and Essential Fatty Acids 70 2004 495 501
27. R. Marchioli, F. Barzi, E. Bomba, C. Chieffo, D. Di Gregorio, R. Di Mascio, MG. Franzosi, E. Geraci, G. Levantesi, A.P. Maggioni, L. Mantini, R.M. Marfisi, G. Mastrogiuseppe, N. Mininni, G.L. Nicolosi, M. Santini, C. Schweiger, L. Tavazzi, G. Tognoni, C. Tucci, and F. Valagussa Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 2002 1897 1903
28. D.L. Musselman, A. Tomer, A.K. Manatunga, B.T. Knight, M.R. Porter, S. Kasey, U. Marzec, L.A. Harker, and C.B. Nemeroff Exaggerated platelet reactivity in major depression American Journal of Psychiatry 153 1996 1313 1317
29. B. Nemets, Z. Stahl, and R.H. Belmaker Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder American Journal of Psychiatry 159 2002 477 479
30. G. Parker, T. Hilton, D. Hadzi-Pavlovic, and J. Bains Screening for depression in the medically ill: the suggested utility of a cognitive-based approach Australian and New Zealand Journal of Psychiatry 35 2001 474 480
31. G. Parker, T. Hilton, J. Bains, and D. Hadzi-Pavlovic Cognitive-based measures screening for depression in the medically ill: the DMI-10 and the DMI-18 Acta Psychiatrica Scandinavica 105 2002 419 426
32. M. Peet, and D.F. Horrobin A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs Archives of General Psychiatry 59 2002 913 919
33. M. Peet, B. Murphy, J. Shay, and D. Horrobin Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients Biological Psychiatry 43 1998 315 319
34. W.E. Severus, A.B. Littman, and A.L. Stoll Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder Harvard Review of Psychiatry 9 2001 280 293
35. R.B. Singh, M.A. Niaz, J.P. Sharma, R. Kumar, V. Rastogi, and M. Moshiri Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4 Cardiovascular Drugs and Therapy 11 1997 485 491
36. A.L. Stoll, W.E. Severus, M.P. Freeman, S. Rueter, H.A. Zboyan, E. Diamond, K.K. Cress, and L.B. Marangell Omega-3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial Archives of General Psychiatry 56 1999 407 412
37. J.J. Strik, R. Lousberg, H.J. Crijns, M. Maes, and A. Honig Relation of levels of serum lipoproteins to depression after acute myocardial infarction American Journal of Cardiology 90 2002 1368 1370
38. K.-P. Su, S.-Y. Huang, C.-C. Chiu, and W.W. Shen Omega-3 fatty acids in major depressive disorder: a double-blind, placebo-controlled trial European Neuropsychopharmacoly 13 2003 267 271
39. World Health Organization Composite International Diagnostic Interview 2.1 CIDI Interview Manual 1997 WHO Geneva, Switzerland